Transcription
CURRICULUM VITAEDate of Preparation of CV:August 2, 2020F. Ellen Loh, B.Pharm., Ph.D., M.B.A.Present Title and AffiliationAssistant ProfessorDepartment of Social, Behavioral and Administrative SciencesTouro College of PharmacyAcademic Appointments2019-presentAdjunct Assistant Professor, Touro Graduate School of Business, New York, NY2017-presentAssistant Professor, Department of Social, Behavioral and Administrative Sciences,Touro College of Pharmacy (TCOP), New York, NY2015-2017Instructor, Department of Social, Behavioral and Administrative Sciences, TouroCollege of Pharmacy, New York, NYEducation2007-2016Ph.D., Pharmaceutical Health Services Research, University of Maryland, Baltimore,MDThesis title: Osteoporosis Medication Use, Adherence and Outcomes in ElderlyEnrolled in Medicare Part DCommittee: Bruce Stuart, PhD (chair), Amy Davidoff, PhD, MS, Marc Hochberg,MD, MPH., Eberechukwu Onukwugha, PhD, MS, Deborah Sturpe, PharmD, MA,BCPS2004-2006M.B.A., Pharmaceutical Business, University of the Sciences in Philadelphia,Philadelphia, PA1999-2004B.Pharm., National Taiwan University, Taipei, TaiwanTraining2005-2007Research Fellow, Center for Pharmaceutical Health Services Research, TempleUniversity School of Pharmacy, Philadelphia, PAHonor and Awards2020Faculty Research Award, TCOPEmerging Leader Award Finalist, ISPE2014Student Poster Fellowship, Drug Information Association (DIA) 50th Annual Meeting2014Travel Fellowship, Graduate Student Association, University of Maryland Baltimore2014, 2011Travel Award, Department of Pharmaceutical Health Services Research, Universityof Maryland, Baltimore2009-present Member, The Rho Chi SocietyF. Ellen Loh C.V. page 1
Academic ServiceInternational2020Core member, ISPE Real World Evidence (RWE) and Data Sources Working GroupExtended member, ISPE-ISPOR Special Joint Task Force2018-present Member, ISPE Pharmacoepidemiology in Pharmacy Education Work GroupMember, ISPOR Medication Adherence and Persistence Special Interest Group2017-present Member, International Society of Pharmacoepidemiology (ISPE) Adherence SpecialInterest GroupMember, ISPE Drug Utilization Research Special Interest GroupMember, International Society of Pharmacoeconomics and Outcomes Research(ISPOR) Faculty Advisor Council2017-2018Member, ISPOR Competency Assessment Work GroupNational2017-present2017-2018Member, PQA Academic Affairs CommitteeMember, PQA Pharmacy Practice and Performance Measurement CommitteeMember, PQA Education and Outreach CommitteeInterim Academic Ambassador, Pharmacy Quality Alliance (PQA)Institutional2020Member, Touro Interdisciplinary Institute on Healthy Aging (TIIHA), Touro Collegeand University System (TCUS)Member, Innovation and Advocacy Task Force, TCOP2019-present Member, Learning Outcomes Committee, TCOPSummer 2019 Chair, Course Evaluation Subcommittee, Assessment Committee, TCOP2018-2019;Member, Assessment Committee, TCOP2015-20172017-present Member, Academic Appeals Committee, TCOP2016-present Vice Chair, Research Committee, TCOPMember, Global Health Committee, TCOP2017-2018Chair, Assessment Committee, TCOPMember, Admission Committee, TCOPMember, Curriculum Committee, TCOPMember, Interprofessional Education Committee, TCOP2016-2018Vice Chair, Co-Curricular and Portfolios Committee, TCOPMember, PharmD/MPH Dual Degree Task Force, TCOP2015-2016Member, Research Committee, TCOPDepartmental2015-present Member, Research Committee, Department of Social, Behavioral and AdministrativeSciences, TCOPProfessional Organizations and SocietiesMemberships and Positions2014-2015;Member, The American Geriatrics Society (AGS)2019-present2017-present Member, Pharmacy Quality Alliance (PQA)Member, American Association of Colleges of Pharmacy (AACP)2016-present Member, International Society for Pharmacoepidemiology (ISPE)F. Ellen Loh C.V. page 2
5;2018-2019Member, Academy of Managed Care Pharmacy (AMCP)Member, AcademyHealthMember, International Society of Pharmacoeconomics and Outcomes Research(ISPOR)Member, American Diabetes Association (ADA)Member, American Heart Association (AHA)Member, The American Public Health Association (APHA)Member, Drug Information Association (DIA)Journal Reviewer2020-present Circulation: Cardiovascular Quality and Outcomes2019-present Journal of Evaluation in Clinical PracticeValue in Health2018-present EpilepsiaInquiry2015-present Health AffairsAmerican Journal of Managed Care2014-present Medical Care2013-present Journal of Managed Care and Specialty PharmacyAmerican Journal of Pharmacy Benefit2010-present Journal of Pharmaceutical Health Services ResearchGrant t of Awareness of Osteoporosis on BMD Testing and Osteoporosis MedicationUse Among Male and Female Medicare BeneficiariesGranting agency: Touro CollegeDirect support amount: 12,800PI: F. Ellen Loh, B.Pharm, Ph.D., M.B.A.Assessing Use of First- and Second-Generation Antipsychotics in Childhood andAdolescent SchizophreniaGranting agency: PQA-CVS Health FoundationDirect support amount: 1,250PI: Brigitte Azzi, BSRole: Mentor2017Effect of Utilization Management Tools on Cost of Pharmacy BenefitsGranting agency: EmpiRx HealthDirect support amount: 0 (sponsor provided data)PI: F. Ellen Loh, B.Pharm, Ph.D., M.B.A.2016-2017Impact of Pharmacogenomic Testing on Physicians’ Prescribing of Chronic PainMedicationsGranting agency: Premier DNAF. Ellen Loh C.V. page 3
Direct support amount: TBAPI: Zvi Loewy, Ph.D.Role: Co-Investigator2015Chartbook of Medication Use and Outcomes for Medicare Part D Enrollees in 2012Granting agency: Pharmaceutical Research and Manufacturers of America (PhRMA)Direct support amount: 43,000PI: Bruce Stuart, Ph.D.Role: Graduate research assistantPrincipal responsibility: Mentored and supervised junior PhD students, coordinatedwith project sponsor, collaborated with team members, constructed analytic datasetsand conducted analyses using the Chronic Condition Data Warehouse (CCW) in SASand Stata, and prepared charts for publication.2014-2015Proximal Predictors and Cost Consequences of Discontinuance with OralHypoglycemic Agents in the ElderlyGranting agency: Merck & Co.Direct support amount: 180,000PI: Bruce Stuart, Ph.D.Role: Graduate research assistantPrincipal responsibilities: Mentored and supervised junior PhD students, coordinatedwith project sponsor, collaborated with team members, designed and conductedanalyses and constructed analytic datasets using the CCW in SAS and Stata.2014How Do Antipsychotic Users Enrolled in MAPDs Differ from Those Enrolled inPDPs?Granting agency: National Institute on Aging (NIA)Trainee: Joshua Chou, B.S.Principal responsibilities: Taught trainee (a PharmD student) study design andstatistical analysis, collaborated with team members, and designed and conductedanalyses using the CCW in SAS.2014Rule of Halves Study on Drug Adherence, Expenditure, and Diabetes Control forMedicare Beneficiaries with Type 2 DiabetesGranting agency: Novo Nordisk and Lewin GroupDirect support amount: 42,625PI: Bruce Stuart, Ph.D.Role: Graduate research assistantPrincipal responsibilities: Mentored and supervised junior PhD student, coordinatedwith project sponsor, collaborated with team members, designed and conductedanalyses and constructed analytic datasets using the CCW in SAS and Stata.2013Effect of Patient Activation on Medication Adherence among Medicare Beneficiarieswith Type II DiabetesGranting agency: NIATrainee: Veronica Foelber, B.S.Principal responsibilities: Taught trainee (a PharmD student) study design andstatistical analysis, collaborated with team members, and designed and conductedanalyses using the Medicare Current Beneficiary Survey (MCBS) in SAS and Stata.2012-2013Medication Adherence and Medicare Expenditure among Beneficiaries with DiabetesF. Ellen Loh C.V. page 4
Granting agency: PhRMADirect support amount: 45,000PI: Bruce Stuart, Ph.D.Role: Graduate research assistantPrincipal responsibilities: Mentored and supervised junior PhD student, coordinatedwith project sponsor, collaborated with team members, designed and conductedanalyses and constructed analytic datasets using the MCBS in SAS and Stata, andprepared a manuscript for publication.2012-2013Chartbook of Medication Utilization Patterns and Outcomes among Part D Enrolleeswith Common Chronic DiseasesGranting agency: PhRMADirect support amount: 55,000PI: Bruce Stuart, Ph.D.Role: Graduate research assistantPrincipal responsibilities: Mentored and supervised junior PhD students, coordinatedwith project sponsor, collaborated with team members, designed and conductedanalyses and constructed analytic datasets using the CCW in SAS and Stata, andprepared charts for publication.2012Effect of Depression on Medication Use and Adherence in Medicare Beneficiarieswith Heart FailureGranting agency: NIATrainee: Kun Yang, B.S.Principal responsibilities: Taught trainee (a Pharm D student) study design andstatistical analysis and designed and conducted analyses using the CCW in SAS andStata.2011-2012Impact of the Doughnut Hole and Catastrophic Coverage on Medicare Beneficiarieswith Heart FailureGranting agency: Novartis PharmaceuticalsDirect support amount: 124,000PI: Bruce Stuart, Ph.D.Role: Graduate research assistantPrincipal responsibilities: Collaborated with team members, designed and conductedanalyses and constructed analytic datasets using the CCW in SAS and Stata, andprepared a manuscript for publication.2011-2012Targeting MTM Services in the Medicare Part D Program: Evaluation of CurrentMethods and Ways to Improve the SystemGranting agency: National Association of Chain Drug Stores (NACDS) and PhRMADirect support amount: 110,263PI: Bruce Stuart, Ph.D.Role: Graduate research assistantPrincipal responsibilities: Designed and conducted analyses and constructed analyticdatasets using the CCW in SAS and Stata, and prepared manuscripts for publication.2008-2011Discharges against Medical Advice among Cardiovascular Disease PatientsGranting agency: National Institute of Health (NIH) Clinical Research ScholarsProgramGrant number: 1K12RR023250-01F. Ellen Loh C.V. page 5
PI: Eberechukwu Onukwugha, Ph.D., M.S.Role: Graduate research assistantPrincipal responsibilities: Conducted analyses and simulations using the State ofMaryland Health Services Cost Review Commission (HSCRC) hospital inpatientclaims data in SAS and Stata, interviewed patients, physicians, nurses and socialworkers to identify reasons for the decision of hospital discharge against medicaladvice, developed a proposal for the NIH R21 grant for a follow-up study andmanuscripts for scientific publication.Educational ContributionsDirect Teaching and Precepting2019-present Lecturer, HCMN 680 Pharmacoeconomics and EpidemiologyFour 1st year master’s studentsTouro Graduate School of Business39 contact hours/year2016-presentLecturer, SBAN 630 Principles of Management, Pharmacoeconomics and OutcomesResearchOne hundred 2nd year PharmD studentsTouro College of Pharmacy12 contact hours/year2015-presentLecturer, “Literature Evaluation, Pharmacoepidemiology and Biostatistics” in SBAN540 Drug Information and Literature EvaluationOne hundred 1st year PharmD studentsTouro College of Pharmacy15 contact hours/year2018-2019Lecturer, SBAN 689 PharmacoeconomicsTwelve 2nd year PharmD students (Spring 2018), nine 2nd year PharmD students(Spring 2019)Touro College of Pharmacy42 contact hours/year2017-2018Lecturer, SBAN 688 PharmacoepidemiologyTwo 2nd year PharmD students (Spring 2017), eleven 2nd year PharmD students (Fall2017), and nine 2nd year PharmD students (Fall 2018)Touro College of Pharmacy42 contact hours/yearLecturer, “Impact of Drug Induced Diseases on the Health Care System” in PHRN782 Drug Induced DiseasesOne hundred 3rd year PharmD studentsTouro College of Pharmacy3 contact hours/year2017Preceptor, PHRN 816 Advanced Pharmacy Practice Education (APPE) ElectiveManaged CareOne 3rd year PharmD studentF. Ellen Loh C.V. page 6
Touro College of Pharmacy240 contact hours/yearLecturer, SBAN 571 Professional Practice II: Patient-Provider CommunicationOne hundred 1st year PharmD studentsTouro College of Pharmacy3 contact hours/yearLecturer, PHRN 590 Independent StudyTwo 4th year PharmD studentsTouro College of Pharmacy42 contact hours/yearLecturer, “Asian-American Patients” in BSCN 620/SBAN 560 Intro to CulturalCompetencyOne hundred and fifty 2nd year DO students and one hundred 1st year PharmDstudentsTouro College of Osteopathic Medicine and Touro College of Pharmacy2 contact hours/yearLecturer, “Asian-American Patients” in HSON 668 Community ServicesForty 2nd year master’s studentsTouro College of Osteopathic Medicine3 contact hours/year2016-2018Lecturer, “Review of Biostatistics” in PHRN 655 Emerging Issues,One hundred 4th year PharmD studentsTouro College of Pharmacy2 contact hours/year2016-2017Lecturer, “Applications of Health Economics and Outcomes Research in ManagedCare” in PHRM 628 Managed CareTwenty-five 2nd year PharmD studentsTouro College of Pharmacy3 contact hours/yearLecturer, “Reflections on Biostatistics” in PHRM 512 Introductory CommunityPharmacy PracticeOne hundred 1st year PharmD studentsTouro College of Pharmacy3 contact hours/yearLecturer, “Reflections on Biostatistics” in PHRM 641 Introductory InstitutionalPharmacy PracticeOne hundred 2nd year PharmD studentsTouro College of Pharmacy3 contact hours/year2016Lecturer, PHRM 510 Foundation of Public Health III: Epidemiology and BiostatisticsTwo 2nd year PharmD studentsTouro College of PharmacyF. Ellen Loh C.V. page 7
56 contact hours/yearAdvising and MentorshipPredoctoral Fellow (Thesis Committee) Elizabeth Deluca, 2017-present. A Program Evaluation to Help Employers Understandthe Value and Relevance of Their Workplace Wellness Program: What Works, What isMissing, and What Needs Improvement. (Department of Public Health, School of HealthSciences and Practice, New York Medical College).Pharmacy Students1. Nisha Wahid, 2020-present, P12. Norin Khandaker, 2020-present, P13. Amal Najjar, 2018-present, P34. Charles Sullivan, 2017-present, P45. Rebecca Walters, 2017-present, P46. Marisabel Zavalunova, 2017-present, P47. Ardita Capric, 2016-2020, graduated in 20208. Luciano Centeno, 2016-2020, graduated in 20209. Jose Gonzalez-Rivera, 2016-2020, graduated in 202010. Nino Katchiuri, 2016-2020, graduated in 2020 (Medical affairs fellowship in internalmedicine in Pfizer)11. Lindsay Petrenchik, 2018-2019, graduated in 201912. Noreen Hussain, 2016-2019, graduated in 201913. Chun Ng-Mei, 2016-2019, graduated in 201914. Sepideh Sahami, 2016-2019, graduated in 201915. Manashe Badalov, 2016-2018, graduated in 201816. Danielle Cabral, 2016-2018, graduated in 2018 (PGY-1 residency in Plainview Hospital)17. Ionit Cohen, 2016-2018, graduated in 201818. Mi Bui, 2016-2017, graduated in 2017 (Staff pharmacist at Rite Aid Pharmacy)19. Stacy Delva, 2016-2017, graduated in 201720. Roksolyana Filipchak, 2016-2017, graduated in 201721. Raj Kumari, 2016-2017, graduated in 2017 (Clinical pharmacist at CVS Health)22. Elisheva Swartz, 2016-2017, graduated in 2017 (Consultant pharmacist at Care OnePharmacy Services, LLC)Educational Administration and Leadership2019-present Course Coordinator, HCMN 680 Pharmacoeconomics and Epidemiology, TouroGraduate School of Business (newly developed course)Founding Faculty Advisor, Pharmacists in Academia, TCOP2018-present Course Coordinator, SBAN 689 Pharmacoeconomics and Outcomes Research, TCOP(newly developed course)2017-present Course Coordinator, SBAN 688 Pharmacoepidemiology, TCOP (newly developedcourse)Founding Faculty Advisor, ISPE Student Chapter, TCOPFounding Faculty Advisor, DIA Student Chapter, TCOP2016-present Course Coordinator, SBAN 630 Principles of Management, Pharmacoeconomics andOutcomes Research, TCOP (newly developed course)Founding Faculty Advisor, ISPOR Student Chapter, TCOPFaculty Advisor, AMCP Student Chapter, TCOP2018Course Coordinator, SBAN 540 Drug Information and Literature Evaluation, TCOPF. Ellen Loh C.V. page 8
20172016Course Coordinator, SBAN 571 Professional Practice II—Patient-ProviderCommunication, TCOP (newly developed course)Course Coordinator, PHRN 590 Independent Study, TCOPCourse Coordinator, PHRM 510 Foundation of Public Health III: Epidemiology andBiostatistics, TCOPCommunity Education2018-present Organizer and participant, Medicare Part D Open Enrollment Consultation, TCOP2016-present Organizer and participant, Medicare Part D Open Enrollment Consultation, SirovichCenter2017Organizer, Junior Achievement of New York Volunteer Teaching, PS 85Organizer and participant, Medicare Part D Open Enrollment Consultation,University Settlement Neighborhood CenterPublicationsPeer-Reviewed Research Publications in Print or Other Media1. Stuart B., Timmons V., Loh F.E., Dai M., Xu J. Can One or Two Simple Questions Predict PoorMedication Adherence? Journal of Evaluation in Clinical Practice. In press. (correspondingauthor)2. Petrenchik L., Loh F.E. Factors Affecting Non-Insulin Antidiabetic Drug Adherence in Patientswith Type 2 Diabetes: A Systematic Review. Current Research in Diabetes and ObesityJournal. 2020;12(5):555848.3. Loh F.E., Stuart B., Davidoff A., Sturpe D., Onukwugha E., Hochberg M. Differences inEvidence-Based Osteoporosis Medication Use between Elderly Men and Women Enrolled inMedicare Part D. Journal of Pharmaceutical Health Service Research. 2019;10(2):187-196.4. Loh F.E., Stuart B., Sturpe D., Davidoff A., Onukwugha E., Hochberg M. OsteoporosisMedication Use: A Comparison of Elderly Female Living in Long-Term Care Facilities vs.Community Dwellers. The Senior Care Pharmacist. 2019;34(2):109-26.5. Yang W., Dall T.M., Tan E., Byrne E., Iacobucci W., Chakrabarti R., Loh F.E. DiabetesDiagnosis and Management among Insured Adults across Metropolitan Areas in the U.S.Preventive Medicine Reports. 2018;10:227-33.6. Chou J., Brandt N., Loh F.E., Stuart B. Do Restriction on Antipsychotic Use Differ BetweenMedicare Part D Stand-Alone versus Medicare Advantage Plans? The Consultant Pharmacist.2017;32(2):109-18.7. Stuart B., Shen X., Quinn C., Brandt N., Roberto P., Loh F.E., Hendrick F., Kim C., Huang X.,Rajpathak S. Proximal Predictors of Discontinuance with Oral Antidiabetic Agents among theElderly. Journal of Managed Care Pharmacy. 2016;22(9):1019-27.8. Tan E., Yang W., Pang B., Dai M., Loh F.E., Hogan P. Geographic Variation in AntidiabeticAgent Adherence and Glycemic Control among Patients with Type 2 Diabetes. Journal ofManaged Care Pharmacy. 2015;21(12):1195-1202.9. Stuart B., Dai M., Xu J., Loh F.E., Shoemaker J.S. Does Good Medication Adherence ReallySave Payers Money? Medical Care. 2015;53(6):517-23.F. Ellen Loh C.V. page 9
10. Loh F-H.E., Stuart B., Zuckerman I.H. Treatment Patterns for Osteoporosis in Elderly WomenResiding in the Community and Long-Term Care Facilities Enrolled in Medicare. Journal ofPharmaceutical Health Services Research. 2015;6(1):19-26.11. Stuart B., Loh F.E., Roberto P.N., Miller L. Incident User Cohorts to Assessing MedicationCost-Offsets. Health Services Research. 2014;49(4):1364-86.12. Stuart B., Loh F.E., Magder L., Shaffer T., Park J., Zacker C. Anticipating Changes in DrugCoverage: How Elderly Heart Failure Patients Respond to Medicare Part D Benefit Phases.Journal of Pharmaceutical Care and Health Systems. 2014;1(1):104.13. Stuart B., Loh F.E., Miller L., Roberto P.N. Should Eligibility for Medication TherapyManagement Be Based on Drug Adherence? Journal of Managed Care Pharmacy.2014;20(1):66-75.14. Stuart B., Loh F.E., Roberto P.N., Miller L. Increasing Medicare Part D Enrollment inMedication Therapy Management Could Improve Health and Lower Costs. Health Affairs.2013;32(7):1212-20.15. Onukwugha E., Saunders E., Mullins C.D. Pradel F.G., Zuckerman M., Loh F.E., Weir M.R. AQualitative Study to Identify Reasons for Discharges against Medical Advice in theCardiovascular Setting. BMJ Open. 2012;2(4):e000902.16. Stuart B., Loh F.E. Medicare Part D Enrollees’ Use of Out-of-Plan Discounted Generic Drugs.Journal of the American Geriatrics Society. 2012;60(2):387-8.17. Onukwugha E., Mullins C.D., Loh F.E., Saunders E., Shaya F.T., Weir M.R. Readmissions afterUnauthorized Discharges in the Cardiovascular Setting. Medical Care. 2011;49(2):215-24.18. Wertheimer A.I., Loh E.F. Making Pharmaceuticals Affordable in Lesser Developed Countries:A Public Health Role for the Pharmacist. Journal of Public Health Pharmacy. 2008;1(1):3-15.Book Review1. Loh F. Book Review of Drugs for Less: The Complete Guide to Free and DiscountedPrescription Drugs, Featuring More Than 600 of The Most Commonly Prescribed Medications,by Michael P. Cecil, MD. New York: Hatherleigh Press, 2005. Journal of PharmaceuticalFinance, Economics and Policy. 2007;15(2):121-23.Book Chapter1. Loh F.E. The Financial and Economic Aspects of Counterfeit Medicines. In CounterfeitMedicines Volume 1: Policy, Economics and Countermeasures. 1st Ed. Albert I. Wertheimer andPerry G. Wang. ILM Publications, Hertfordshire, UK, 2012.Editorial1. Loh F.E., Herzig S. J. Pain in the United States: Time for a Culture Shift in Expectations,Messaging, and Management. Journal of Hospital Medicine. 2019;14(12):787-8.F. Ellen Loh C.V. page 10
Book1. Stuart B., Loh F.E., Xu J., Roberto P.N., Shoemaker J.S. Medication Utilization Patterns andOutcomes among Part D Enrollees with Common Chronic Diseases. PhRMA, Washington, DC,2014.Letter to Editor1. Stuart B., Loh F.E. Response Letter to Jonathan Harding. Journal of the American GeriatricsSociety. 2013;61(2):310.Other Non-Peer Reviewed Publication in Print or Other Media1. Brock S.E., Loewy Z.G., Loh F.E. Team Skills: Comparing Pedagogy in a Graduate BusinessSchool to That of a College of Pharmacy Professional Program. Proceedings of the 2017 InSITEConference. 2017;11-20.2. Wertheimer A.I., Loh E.F. Getting Value from End-of-Life-Cycle Pharmaceuticals.Pharmaceutical Commerce. 2009;4(9).3. Wertheimer A.I., Loh E.F., Poli L.G. Lifecycle: End Game. Pharmaceutical Executive.2007;27(10):106-11.4. Wertheimer A.I., Loh F. Getting Better? Pharmaceutical Executive. 2006;26(8):72-84.Work in Progress2. Addo-Atuah J., Senhaji-Tomza B., Ray D., Basu P., Loh F.E., Owusu-Daaku F. Global HealthResearch Partnerships in the Context of the Sustainable Development Goals. Research in Socialand Administrative Pharmacy. Under review.3. McDaniel C., Loh F.E., Rockwell D., McDonald C., Chou C. Burden of Diabetes and AmongMedicare Beneficiaries with Cancer. Diabetes Care. Under review.4. Loh F.E., Azzi B., Weingarten A., Loewy Z. Impact of Pharmacogenomic Testing onPhysicians’ Prescribing of Chronic Pain Medications and Patient Pain Control.Pharmacogenomics. In preparation for submission.5. Loh F.E., Stuart B., Davidoff A., Onukwugha E., Sturpe D., Hochberg M. Prescription TimeDistribution Matching, Inverse Probability Weighting, and Competing Risk of Death forAssessing Effectiveness of Osteoporosis Medications in Reducing Risk of Fracture.Pharmacoepidemiology and Drug Safety. In preparation for submission.6. Naeem A., Shah M., Adrawy J., Chamalov I., Loh F.E. Effectiveness of Crisaborole 2% inTreating Atopic Dermatits in Individuals Age 2 Years and Older: A Systematic Review.Dermatology Online Journal. In preparation for submission.7. Chou C., McDaniel C., McDonald C., Rockwell D., Loh F.E. Comparing Claims and Surveydata from the Medicare Current Beneficiary Survey to estimate the Financial Burden of Diabetesamong Elderly Medicare Beneficiaries with Cancer. In preparation for submission.8. Loh F.E, McDaniel C., McDonald C., Rockwell D., Chou C. Quality of Diabetes Care amongElderly Medicare Beneficiaries with Cancer. In preparation for submission.F. Ellen Loh C.V. page 11
9. Najjar A., Loh F.E. Difference in Awareness of Osteoporosis between Men and Women: ASystematic Review.10. Najjar A., Loh F.E. Impact of Awareness of Osteoporosis on Receipt of BMD Testing: ASystematic Review.11. Najjar A., Loh F.E. Impact of Awareness of Osteoporosis on Osteoporosis Medication Use: ASystematic Review.12. Loh F.E., Najjar A.Difference in Awareness of Osteoporosis between Men and Women13. Loh F.E., Najjar A.Impact of Awareness of Osteoporosis on Receipt of BMD Testing.14. Loh F.E., Najjar A.Impact of Awareness of Osteoporosis on Osteoporosis Medication Use.Peer-Reviewed Abstracts/Poster Presentations1. Najjar A., Loh F.E. Effect of Awareness of Osteoporosis on Osteoporosis Medication Use andAdherence: A Systematic Review. Academy of Managed Care Pharmacy (AMCP) NexusMeeting, Las Vegas, NV, Oct. 22, 2020.2. Najjar A., Loh F.E. Difference in Awareness of Osteoporosis among Men and Women: ASystematic Review. American Geriatrics Society (AGS) Annual Scientific Meeting, Long Beach,CA, May 8, 2020.3. Nwosu O., Omoniyi A., Andoh J., Kipling J., Loh F.E. A Systematic Review of Ixekizumab forthe Treatment of Moderate-To-Severe Chronic Plaque Psoriasis. A Systematic Review. Academyof Managed Care Pharmacy (AMCP) Annual Meeting, Houston, TX, Apr. 23, 2020.4. Rockwell D., McDonald C., McDaniel C., Loh F.E., Chou C. Trends in Healthcare Cost Affirmthe Financial Burden of Diabetes among Medicare Beneficiaries with Cancer. American Societyof Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition, Las Vegas,NV, Dec. 8-12, 2019.5. McDaniel C., McDonald C., Rockwell D., Loh F.E., Chou C. Disparities in Quality of DiabetesCare and Health Care Spending among Cancer Patients with Diabetes: An Investigation of aNationally Representative Sample of Medicare Beneficiaries. American Society of HealthSystem Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition, Las Vegas, NV, Dec. 812, 2019.6. George S.A., Kaur J., Patel D., Loh F.E. Effectiveness of Alirocumab as an Add-On Therapy toStatins Compared with Statins Alone in Hypercholesterolemia: A Systematic Review. AmericanSociety of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition, LasVegas, NV, Dec. 10, 2019.7. Fontenelle R., Dixit G., Yaguda D., Paddy J., Loh F.E. Is Meloxicam More Effective inTreatment Osteoarthritis Compared to Other NSAIDs (Tramadol, Naproxen, Acetaminophen)?American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting andExhibition, Las Vegas, NV, Dec. 10, 2019.8. Omoniyi A., Nwosu O., Kipling J., Andoh J., Loh F.E. A Systematic Review of Ixekizumab forthe Treatment of Moderate-To-Severe Chronic Plaque Psoriasis. American Society of Health-F. Ellen Loh C.V. page 12
System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition, Las Vegas, NV, Dec. 10,2019.9. Sarvaiya D., Darwish D., Najjar A., Tunden Y., Loh F.E. Improved Safety and Efficacy withDupilumab in Adult Patients with Atopic Dermatitis Compared to Calcineurin Inhibitors orTopical Corticoids: A Systematic Review. American Society of Health-System Pharmacists(ASHP) Midyear Clinical Meeting and Exhibition, Las Vegas, NV, Dec. 10, 2019.10. Sen P., Saadeh B., Loh F.E. Role of CAR-T Cells Therapy in Diffuse Large B-Cell Lymphoma(DLBCL). International Society of Pharmacoeconomics and Outcomes Research (ISPOR)Europe 2019 Conference, Copenhagen, Denmark, Nov. 4, 2019.11. Naeem A., Shah M., Adrawy J., Chamalov I., Loh F.E. Effectiveness of Crisaborole 2% inTreating Atopic Dermatits in Individuals Age 2 Years and Older: A Systematic Review.Academy of Managed Care Pharmacy (AMCP) Nexus Meeting, National Harbor, MD, Oct. 31,2019.12. Bloomfield K., Briggs P., Miranda A., Paulino G., Loh F.E. A Systematic Review of theEfficacy and Torerability of Flibanserin in thr Treatment of Hypoactive Sexual Desire Disorderin Premenopausal Women. Academy of Managed Care Pharmacy (AMCP) Nexus Meeting,National Harbor, MD, Oct. 31, 2019.13. Mlabasati M., El-Sheikh-Ali R., Loh F.E. Cost-Effectiveness of Triumeq, A Combination ofDolutegravir, Abacavir, and Lamivudine Drugs for the Treatment of HIV Infections. Academy ofManaged Care Pharmacy (AMCP) Nexus Meeting, National Harbor, MD, Oct. 31, 2019.14. Abdelmalak K., Patel R., Loh F.E. Cost-Effectiveness of Sacubitril/Valsartan in the Treatmentof Heart Failure: A Systematic Review. American College of Clinical Pharmacy (ACCP) AnnualMeeting, New York, NY, Oct. 26, 2019.15. Hossain A., Calvin A., Kaitlyn I., Kaur N., Loh F.E. The Advantages and Disadvantages ofEvolocumab for the Treatment of Hypercholesterolemia and Cardiovascular Disease: ASystematic Review. American College of Clinical Pharmacy (ACCP) Annual Meeting, NewYork, NY, Oct. 26, 2019.16. Kim D., Centeno L., Loh F.E. The Use of Isoproterenol for Ventricular Fibrillation in BrugadaSyndrome. International Society of Pharmacoepidemiology (ISPE) 12th Asia Conference, Kyoto,Japan, Oct. 11-13, 2019.17. Patel R., Englard A., Loh F.E. Cost-Effectiveness of Evolocumab in Treating CardiovascularDisease. International Society of Pharmacoepidemiology (ISPE) 12th Asia Conference, Kyoto,Japan, Oct. 11-13, 2019.18. Patel R., Loh F.E. A Systematic Review of Ketamine for Treatment-Resistant Depression. 35thInternational Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE),Philadelphia, PA, Aug. 26, 2019.19. Azzi B., Loh F.E. A Systematic Review of the Safety and Efficacy of First- and SecondGeneration Antipsychotics in Childhood and Early-Onset Schizophrenia. Pharmacy QualityAlliance (PQA) 4th Annual Meeting, Baltimore, MD, May 16, 2019.F. Ellen Loh C.V. page 13
20. Izrailova K., Vagudayev V., Zabih D., Quintero R., Khalid A., Loh F.E. Vedolizumab: What Isthe Most Cost-Effective Drug Therapy in Treating Inflammatory Bowel Disease? A SystematicReview. Academy of Managed Care Pharmacy (AMCP) Annual Meeting, San Diego, CA, Mar.27, 2019.21. Kim D., Centeno L., Loh F.E. Comparative Effectiveness of Meditation vs. Methylphenidate inPatients with ADHD. American Society of Health-System Pharmacists (ASHP) Midyear ClinicalMeeting and Exhibition, Anaheim, CA, Dec. 4, 2018.22. Oh J., Tsitarava M., Loh F.E. Should
Touro College of Pharmacy . Academic Appointments . 2019-present Adjunct Assistant Professor, Touro Graduate School of Business, New York, NY . . Touro Graduate School of Business 39 contact hours/year . 2016-present Lecturer, SBAN 630 Principles of Management, Pharmacoeconomics and Outcomes Research 2: nd.
